Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

Yes, typically if a placebo is given, a study would be blinded. That way it can truly be a placebo... if it was open, that would defeat the purpose. However, that is NOT what we have here with Algernon. As mentioned by AMG, there is no placebo. We have an open label (NON blinded) trial. Instead of placebo, we have standard of care, meaning regular best medical treatment. The treatment groups get low or high dose of drug.